"Phase I trials imminently"10 Sep 2024 08:35
We are excited to begin our Phase I trials imminently at MD Anderson Cancer Center, a leading institution in cancer care, and look forward to expanding our efforts to the University of Pennsylvania Medical Center.
Nothing else right now at Hemogenyx matters , the visibilty and exposure that comes with human trials is something that money cannot buy. No RNS or interview or report will come close to the potential for PR that first human injection brings. When this happens traders/shorters etc will be irrelevant, if we see inward investment from a new pool of eyes many wont even be aware of this god forsaken site :-) How many will invest???? None of us know, we dont know who is waiting on the sidelines for the first injection and we dont know what sort of marketing MD Anderson etc will carry out. The key word is "imminently" having completed an unexpected assay in Americas leading cancer treatment center.
Imminent does NOT mean this week, even if someone is selected it will take a further 10 days to produce the HEMO-CAR-T so stu and other traders have atleast 2 weeks to "have a go", expect to see lots and lots of full page essays from Stu in the coming days as he tries to deflect, detract and distract from the significance of the transformative stage we are in right now. History is history but Hemogenyx has NEVER treated a human before, WE have never experienced the media coverage that actual Human trials can bring, none of us know what will happen so dont be hoodwinked into thinking the traders know better, they just want a short term trade and will say whatever is necessary to do so.
Anyone who cannot see the opportunity here needs to visit specsavers :-)
Have a great day Shareholders!
This share price is NOT sustainable, it will not last, FINALLY the day of the LTH is coming and it is going to taste so delicious!